Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12694]

Combined melanoma treatment may be model for treating other cancers

Combined melanoma treatment may be model for treating other cancers

Combination of PI3-kinase and PARP Inhibitors may offer new treatment option for triple-negative breast cancers

Combination of PI3-kinase and PARP Inhibitors may offer new treatment option for triple-negative breast cancers

Black patients with kidney cancer have poorer survival than whites

Black patients with kidney cancer have poorer survival than whites

Higher dietary glycemic load linked to worse colon cancer survival

Higher dietary glycemic load linked to worse colon cancer survival

Mesothelioma drug slows disease progression in patients with an inactive NF2 gene

Mesothelioma drug slows disease progression in patients with an inactive NF2 gene

NCRI 2012: From cancer genomes to personalised medicine

NCRI 2012: From cancer genomes to personalised medicine

Researchers develop non-invasive technique for predicting patients’ response to chemotherapy

Researchers develop non-invasive technique for predicting patients’ response to chemotherapy

Patients with aberrations in two genes respond better to drugs blocking a well-known cancer pathway

Patients with aberrations in two genes respond better to drugs blocking a well-known cancer pathway

New targeted therapy for advanced prostate cancer shows anti-tumour activity in phase I clinical trials

New targeted therapy for advanced prostate cancer shows anti-tumour activity in phase I clinical trials

Positive NICE decision on ipilimumab, the first treatment for advanced melanoma to be licensed in the UK for over 30 years

Positive NICE decision on ipilimumab, the first treatment for advanced melanoma to be licensed in the UK for over...

More from ecancer